Cosfroviximab Antibody
Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody targeting the Ebola virus glycoprotein (EBOV-GP) . It is utilized in research for investigating Ebola virus neutralization and pathogenesis in both in vitro and in vivo experimental models.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog